Combination Drug Therapy (Combination Chemotherapy)

Subscribe to Selected New Research on Combination Drug Therapy

8322 relevant articles (991 outcomes, 1270 trials/studies) found for this Therapy

Description: Therapy with two or more separate preparations given for a combined effect.

Also Known As:

Combination Chemotherapy; Drug Therapy, Combination; Chemotherapy, Combination; Therapy, Combination Drug; Chemotherapies, Combination; Combination Chemotherapies; Combination Drug Therapies; Drug Therapies, Combination; Polychemotherapies; Therapies, Combination Drug; Polychemotherapy

Relationship Network

Therapy Context: Research Results

Therapeutics: 5192

Drug Therapy: 116577

Combination Drug Therapy: 8322

Highly Active Antiretroviral Therapy: 4514

Antineoplastic Combined Chemotherapy Protocols: 16

Experts

1.	Kang, Yoon-Koo: 7 articles (12/2008 - 10/2004)
2.	Monden, Morito: 6 articles (04/2008 - 01/2004)
3.	Ryu, Min-Hee: 5 articles (12/2008 - 10/2004)
4.	Tanimoto, Mitsune: 5 articles (01/2008 - 05/2002)
5.	Sakata, Yuh: 5 articles (01/2008 - 10/2006)
6.	Dimopoulos, M A: 5 articles (12/2007 - 09/2001)
7.	Fountzilas, G: 5 articles (12/2007 - 02/2000)
8.	Kumai, Koichiro: 5 articles (08/2007 - 03/2003)
9.	Kubota, Tetsuro: 5 articles (08/2007 - 03/2003)
10.	Kitajima, Masaki: 5 articles (08/2007 - 03/2003)

Related Diseases

1.	Neoplasms (Cancer) 07/01/2005 - "Most institutes participated in nonrandomized trials designed to evaluate the safety and efficacy of combination chemotherapy, surgery, and radiotherapy in each group study and treated children with these tumors The results are reviewed and areas for future investigation are identified." 11/01/2004 - "The best results were achieved in patients with pT2A tumor invasion depth, G1 differentiation of tumor cells after TUR with adjuvant polychemotherapy (PCT) recurrences in these patients arose by 41.2% less frequently than in patients after TUR only, 5-year survival in patients after TUR+PCT was 83.3%" 06/01/1999 - "With the consistent use of effective multimodal treatment, including combination chemotherapy, surgery and radiotherapy, the prognosis for all types of childhood cancer has dramatically improved over the last 25 years and the current 5-year survival rate is about 60-98%" 01/01/1990 - "The polychemotherapy followed by the radiotherapy should be preferably applied to patients with tumors of the disease group A, because in this group the best results were obtained with an average survival time of 21.3 months, a remission length of 13.4 months, an improvement of life quality for 12.5 months and a high remission rate" 03/01/1989 - "The stage of disease at the time of the original procedure greatly influences the results, and, as would be anticipated, the results are infinitely better in those patients who have a second-look operation after Stage I cancer has been diagnosed than in patients who have a second-look procedure after an initial staging of Stage III. The best results will be achieved in those patients who have had very aggressive surgery at the initial procedure--followed by combination chemotherapy for approximately six to nine months.(ABSTRACT TRUNCATED AT 250 WORDS)" Get all the results and reference details, order at left...
2.	Carcinoma (Carcinomatosis) 07/01/1991 - "The aim of our study was to evaluate the role of fiberoptic bronchoscopy both in diagnosing patients with small cell lung carcinoma and in assessing complete remission following combination chemotherapy" 02/01/1994 - "Because of the rarity of the primary fallopian tube carcinoma, optimal primary therapy is still not well defined, and there is little information available regarding the efficacy of combination chemotherapy in advanced disease" 12/01/1987 - "Because the follow-up of these patients suggests a marked improvement in outcome compared with similar patients treated traditionally with mastectomy or radiotherapy followed by adjuvant chemotherapy, we advocate more widespread use of combination chemotherapy before definitive treatment for stage III carcinomas of the breast." 08/01/1986 - "Complete remission with combination chemotherapy in metastatic breast carcinoma." 06/01/1986 - "Abdominopelvic irradiation was given to 18 stage II-IV ovarian carcinoma patients who completed cisplatinum-based combination chemotherapy, were in complete clinical remission, and who underwent second-look laparotomy" Get all the results and reference details, order at left...
3.	Hodgkin Disease (Hodgkin's Disease) 07/15/1995 - "Patients with Hodgkin's disease (HD) who fail to enter a complete remission after an initial course of combination chemotherapy are usually considered to have an induction failure (IF); this subset of patients has an extremely poor outcome with further conventional therapy" 09/01/1988 - "Combination chemotherapy has dramatically improved the prognosis of patients with intermediate and high grade histologic subtypes of non-Hodgkin's lymphomas" 02/01/1992 - "PATIENTS AND METHODS: Study population comprised 107 patients with Hodgkin's disease treated with combination chemotherapy at the National Cancer Institute who relapsed after achieving a complete remission" 01/01/1991 - "Initial results from studies with third-generation combination chemotherapy regimens for the treatment of aggressive non-Hodgkin's lymphomas (NHL) demonstrated complete remission (CR) rates higher than those reported with first-generation regimens" 08/01/2004 - "Consolidation radiotherapy may improve outcomes in people with Hodgkin's disease achieving complete remission after combination chemotherapy." Get all the results and reference details, order at left...
4.	Small Cell Carcinoma (Small Cell Lung Cancer) 01/01/2003 - "Combination chemotherapy has been shown to improve overall survival compared with best supportive care in patients with advanced non-small cell lung cancer (NSCLC)" 01/01/1986 - "The treatment of patients with small cell carcinoma of the lung (SCCL) with combination chemotherapy and radiation has dramatically improved survival in the past decade" 05/01/1992 - "CONCLUSION: In patients with a relapse of small cell lung cancer after a complete initial response and prolonged remission retreatment with the initial combination chemotherapy cannot be dismissed and requires further study." 02/01/2004 - "An evidence-based practice guideline was developed to identify the optimal combination chemotherapy regimen, schedule of administration, and duration of therapy for the first-line treatment of adults with limited-stage small-cell lung cancer" 05/01/1999 - "After complete or partial remission is achieved by the combination chemotherapy, surgical resection may be recommended as the second therapy that occasionally produces long-term remission and possibly long-term survival for patients with small cell carcinoma of the esophagus, such as the present case." Get all the results and reference details, order at left...
5.	Neoplasm Metastasis (Metastasis) 10/01/1981 - "The best results were obtained with the use of the polychemotherapy in combination with radiotherapy: the index of the 3-year survival amounted to 38.5+/-14 per cent, while in the patients subjected to the monochemotherapy in combination with irradiation of the metastases it was equal to 3.8+/-3.7 per cent" 05/19/1978 - "If remission is not achieved with combined hormonal and cytostatic treatment, radiotherapy to the choroid metastases in combination with polychemotherapy can be undertaken as second best." 10/10/2008 - "The rapid expansion in the use of improved combination chemotherapy regimens plus or minus biologics, to render initially unresectable metastases resectable has increased the percentage of patients eligible for potentially curative surgery" 03/01/2007 - "In patients with distant lymph-node metastasis, even without adjacent organ invasion, radical surgery may not achieve a good outcome.1 Here, combination chemotherapy or chemo-radiotherapy may have some benefits." 10/01/1997 - "CONCLUSIONS: Continuous-course radiotherapy and concurrent combination chemotherapy is an intensive, toxic but tolerable treatment regimen, which, when compared with radio therapy alone, can produce an improvement in relapse-free survival, a decrease in distant metastases, and an improvement in overall survival with successful primary site preservation." Get all the results and reference details, order at left...
606 Diseases and 8322 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	Cisplatin (Platino)
2.	Cyclophosphamide (Cytoxan)
3.	Doxorubicin (Adriamycin)
4.	Fluorouracil (Carac)
5.	Etoposide (VP 16)
6.	Paclitaxel (Taxol)
7.	Vincristine (Oncovin)
8.	Methotrexate (Mexate)
9.	Platinum
10.	Carboplatin (JM8)
817 Drugs and Important Bio-Agents and 4709 more articles analyzed in the Research Interface, order at left...

Related Therapies and Procedures

1.	Drug Therapy (Chemotherapy)
2.	Adjuvant Chemotherapy
3.	Salvage Therapy
4.	Laparotomy
5.	Aftercare (After-Treatment)
99 Therapies and Procedures and 1055 more articles analyzed in the Research Interface, order at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>